Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06450067
Status:
RECRUITING
Last Update Posted:
2024-06-13
First Post:
2024-06-03
Brief Title:
Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia
Sponsor:
Juventas Cell Therapy Ltd
Organization:
Juventas Cell Therapy Ltd
Organization Data
Organization:
Juventas Cell Therapy Ltd
Class:
INDUSTRY
Study ID:
HY001402
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Juventas Cell Therapy Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None